| Dr Gurjot Kaur Basra, MD | |
|
2900 2nd Ave, Lake Charles, LA 70601-8906 | |
| (337) 480-8994 | |
| (337) 480-8993 |
| Full Name | Dr Gurjot Kaur Basra |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 16 Years |
| Location | 2900 2nd Ave, Lake Charles, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760703763 | NPI | - | NPPES |
| 2452266 | Medicaid | LA | |
| MD.207980 | Other | LA | LSBME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD207980 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Charles Memorial Hospital | Lake charles, LA | Hospital |
| Beauregard Memorial Hospital | Deridder, LA | Hospital |
| West Calcasieu Cameron Hospital | Sulphur, LA | Hospital |
| Jennings American Legion Hospital | Jennings, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lake Charles Medical Services Family Practice Associates, Llc | 1052481504 | 17 |
News Archive
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.
inVentiv Health Clinical, a leading global supplier of drug development services, today announced the launch of an innovative, web-based network to efficiently connect physicians interested in participating in late-stage research to appropriate clinical trials.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment.
› Verified 6 days ago
| Entity Name | Lake Charles Medical Services Family Practice Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396926069 PECOS PAC ID: 1052481504 Enrollment ID: O20080610000427 |
News Archive
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.
inVentiv Health Clinical, a leading global supplier of drug development services, today announced the launch of an innovative, web-based network to efficiently connect physicians interested in participating in late-stage research to appropriate clinical trials.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gurjot Kaur Basra, MD Po Box 122539 Dept 2539, Dallas, TX 75312-2539 Ph: (337) 494-2772 | Dr Gurjot Kaur Basra, MD 2900 2nd Ave, Lake Charles, LA 70601-8906 Ph: (337) 480-8994 |
News Archive
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.
inVentiv Health Clinical, a leading global supplier of drug development services, today announced the launch of an innovative, web-based network to efficiently connect physicians interested in participating in late-stage research to appropriate clinical trials.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment.
› Verified 6 days ago
Robin Ann Rougeau, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 555 South Ryan St, #101, Lake Charles, LA 70601 Phone: 337-439-0762 Fax: 337-436-8862 | |
Dr. Jean King White, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. William R Condos Jr., M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1717 Oak Park Blvd, Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Leroy E Fredericks, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 210, Lake Charles, LA 70601 Phone: 337-494-6768 Fax: 337-494-6792 | |
Gerald W Byrd, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 501 Dr Michael Debakey Dr, Lake Charles, LA 70601 Phone: 337-433-8400 Fax: 337-433-7350 | |
Hari Bogabathina, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Eric Charles Fontenot, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 345, Lake Charles, LA 70601 Phone: 337-494-4785 Fax: 337-494-4786 |